Autophagy and Neurodegeneration
自噬和神经变性
基本信息
- 批准号:8120241
- 负责人:
- 金额:$ 34.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAutomobile DrivingAutophagocytosisAutophagosomeBiochemistryBiological AssayBrainCell LineCellsComplexCoupledCryoelectron MicroscopyDegradation PathwayDisciplineDiseaseDisease ProgressionFunctional disorderGoalsGrantHealthHeartHela CellsHepatocyteHomologous GeneHuntington DiseaseIndiumLabelLeadLinkLipidsLysosomal Storage DiseasesMammalian CellMembraneNatureNerve DegenerationNeurodegenerative DisordersNeurologic DysfunctionsNeuronal DysfunctionNeuronsOnionsOrganellesParkinson DiseasePathogenesisPathologyPopulationPrevalenceProcessProteinsProteomeProteomicsRegulationResearchRoleStructureTherapeuticTissuesTransgenic MiceVacuoleVesicleYeastsbasebrain cellcell typedesigneffective therapyin vivoinsightinterestnovel strategiesparticleprotein degradationstable cell line
项目摘要
DESCRIPTION (provided by applicant): Project Summary Over the last several years, macroautophagy has been implicated in a wide array of neurodegenerative disorders from the aggregation prone disorder, Huntington's disease to the lysosomal storage disorders, Neiman-Pick Type C. Despite its prevalence however, macroautophagy is still poorly understood, making it difficult to define how it contributes towards pathogenesis. Perhaps unsurprisingly, in different disorders, macroautophagy has been considered both as a potentially causative and potentially ameliorative element in disease progression. If we are to target this complex degradative pathway for therapeutics, we need to better define the autophagic process in a means we can apply it towards the brain. In this grant submission, we propose to gain new insights into macroautophagy by focusing on the key organelle involved: the autophagic vacuole (AV). Defined as an onion-like multilamellar vesicle that is positive for the marker MAP1LC3 (a mammalian homologue of ATG8), the formation and maturation of this structure is at the heart of the autophagic process and is by far the least understood. Using a novel approach which we have developed that can isolate specific populations of AV for proteomic and lipid-based analyses, we will: 1) characterize AVs from neuronal cells and brain; 2) compare and contrast MAP1LC3- labeled AVs from vesicles labeled with the other four ATG8 mammalian homologues; and 3) use functional cell based assays to further define how the various ATG8- proteomes impact macroautophagy. PUBLIC HEALTH RELEVANCE: Macroautophagy is a poorly understood process that is important for allowing cells, such as neurons to get rid of proteins that no longer function. Interestingly, this process has been implicated to be at the heart of many neurodegenerative diseases such as Huntington's disease, Parkinson's disease, Alzheimer's disease, many lysosomal storage diseases and others. Here we propose to study macroautophagy as it pertains to the brain so that we can use this information to design effective treatment for these many diseases.
描述(由申请人提供):项目摘要在过去的几年里,巨自噬与一系列神经退行性疾病有关,从聚集倾向障碍、亨廷顿病到溶酶体储存障碍、内曼-皮克C型。然而,尽管巨自噬很普遍,但人们对它的了解仍然很少,因此很难定义它是如何在发病机制中起作用的。也许并不令人惊讶的是,在不同的疾病中,巨自噬被认为是疾病进展中的一个潜在的致病因素和潜在的改善因素。如果我们要针对这种复杂的降解途径进行治疗,我们需要更好地定义自噬过程,以一种我们可以将其应用于大脑的方式。在这份拨款申请中,我们建议通过关注涉及的关键细胞器:自噬空泡(AV)来获得对宏观自噬的新见解。这种结构的形成和成熟是自噬过程的核心,目前人们对此知之甚少。使用我们开发的一种新的方法,可以分离特定的AV群体用于蛋白质组学和基于脂质的分析,我们将:1)从神经细胞和大脑鉴定AVs;2)比较和对比MAP1LC3标记的AVs和其他四种ATG8哺乳动物同源物标记的小泡的AVs;以及3)使用基于功能细胞的分析来进一步确定各种ATG8蛋白质组如何影响宏自噬。与公共卫生相关:宏自噬是一个知之甚少的过程,对于允许细胞(如神经元)去除不再起作用的蛋白质非常重要。有趣的是,这一过程被认为是许多神经退行性疾病的核心,如亨廷顿病、帕金森病、阿尔茨海默病、许多溶酶体储存疾病和其他疾病。在这里,我们建议研究宏观自噬,因为它与大脑有关,这样我们就可以利用这些信息来设计对这些许多疾病的有效治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas James Melia其他文献
Thomas James Melia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas James Melia', 18)}}的其他基金
Lipid flux during autophagosome membrane biogenesis
自噬体膜生物发生过程中的脂质通量
- 批准号:
10331030 - 财政年份:2020
- 资助金额:
$ 34.51万 - 项目类别:
Lipid flux during autophagosome membrane biogenesis
自噬体膜生物发生过程中的脂质通量
- 批准号:
10561660 - 财政年份:2020
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the Atg8 Family of Proteins
Atg8 蛋白家族对自噬体膜动力学的调节
- 批准号:
10544093 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the AtgB Family of Proteins
AtgB 蛋白家族对自噬体膜动力学的调节
- 批准号:
8435915 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the Atg8 Family of Proteins
Atg8 蛋白家族对自噬体膜动力学的调节
- 批准号:
9239658 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the AtgB Family of Proteins
AtgB 蛋白家族对自噬体膜动力学的调节
- 批准号:
8986795 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the Atg8 Family of Proteins
Atg8 蛋白家族对自噬体膜动力学的调节
- 批准号:
10051183 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the Atg8 Family of Proteins
Atg8 蛋白家族对自噬体膜动力学的调节
- 批准号:
10312028 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
Regulation of Autophagosome Membrane Dynamics by the AtgB Family of Proteins
AtgB 蛋白家族对自噬体膜动力学的调节
- 批准号:
8598911 - 财政年份:2013
- 资助金额:
$ 34.51万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 34.51万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 34.51万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 34.51万 - 项目类别:














{{item.name}}会员




